BIOTIME INC
SC 13D, 1999-04-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIOTIME INC, 4, 1999-04-09
Next: BIOTIME INC, SC 13D, 1999-04-09




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

         SCHEDULE 13D
          Under the Securities Exchange Act of 1934 (Amendment No. 5)*


                                  BioTime, Inc.

                                (Name of Issuer)

                           Common Shares, no par value

                         (Title of Class of Securities)

                                    09066L105

                                 (CUSIP Number)

                          Paul Segall and Judith Segall
          935 Pardee Street, Berkeley, California 94710; (510) 845-9535

       (Name, Address and Telephone Number of Person Authorized to Receive
                            Notices and Communications)

                                  March 9, 1999

              (Date of Event which Requires Filing this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f), or 240.13d-1(g), check the
following box [ ].

NOTE:  Schedules  filed in paper format shall include a signed original and five
copies of the schedule,  including all exhibits.  See  ss.240.13d-7(b) for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

                               Page 1 of 7 Pages
<PAGE>




CUSIP No. 09066L105

         1)       Names of Reporting Persons S.S. or I.R.S. Identification Nos.
                  of Above Persons
                           Paul Segall

         2)       Check the Appropriate Box if a Member of a Group 
                  (See Instructions)
                           (a) [ ]
                           (b) [ ]
         3)       SEC Use Only

         4)       Source of Funds (See Instructions)
                           PF; OO

         5)       Check if Disclosure of Legal Proceedings is Required Pursuant
                  to Items 2(d) or 2(e) [ ]

         6)       Citizenship or Place of Organization
                           U.S.A.

                  7)       Sole Voting Power
Number of                           543,245
Shares
Beneficially      8)       Shared Voting Power
Owned by                   0
Each
Reporting         9)       Sole Dispositive Power
Person With                         543,245

                  10)      Shared Dispositive Power
                                    0

         11)      Aggregate Amount Beneficially Owned by Each Reporting Person
                           745,408

         12)      Check if the Aggregate Amount in Row (11) Excludes Certain 
                  Shares (See Instructions)    [ ]

         13)      Percent of Class Represented by Amount in Row (11)
                           6.9%

         14)      Type of Reporting Person (See Instructions)
                           IN


                               Page 2 of 7 Pages
<PAGE>


CUSIP No. 09066L105

         1)       Names of Reporting Persons S.S. or I.R.S. Identification Nos.
                  of Above Persons
                           Judith Segall

         2)       Check the Appropriate Box if a Member of a Group 
                  (See Instructions)
                           (a) [ ]
                           (b) [ ]
         3)       SEC Use Only

         4)       Source of Funds (See Instructions)
                           PF; OO

         5)       Check if Disclosure of Legal Proceedings is Required Pursuant
                  to Items 2(d) or 2(e) [ ]

         6)       Citizenship or Place of Organization
                           U.S.A.

                  7)       Sole Voting Power
Number of                           202,163
Shares
Beneficially      8)       Shared Voting Power
Owned by                   0
Each
Reporting         9)       Sole Dispositive Power
Person With                         202,163

                  10)      Shared Dispositive Power
                                    0

         11)      Aggregate Amount Beneficially Owned by Each Reporting Person
                           745,408

         12)      Check if the Aggregate Amount in Row (11) Excludes Certain 
                  Shares (See Instructions)    [ ]

         13)      Percent of Class Represented by Amount in Row (11)
                           6.9%

         14)      Type of Reporting Person (See Instructions)
                           IN

                               Page 3 of 7 Pages
<PAGE>



Item 1.  Security and Issuer

         The class of equity securities to which this schedule relates is Common
Shares,  no par value (the  "Common  Shares"),  of BioTime,  Inc.,  a California
corporation (the "Company").  The Company has its principal executive offices at
935 Pardee Street, Berkeley, California 94710.

         This  schedule  is  being  filed  pursuant  to  Section  13(d)  of  the
Securities  Exchange Act of 1934, as amended (the "Exchange  Act") and the rules
and regulations promulgated thereunder.

Item 2.  Identity and Background

(a) The names of the  persons  filing this  schedule  are Paul Segall and Judith
Segall.

(b)      The business address of Paul Segall and Judith Segall is 935 Pardee 
         Street, Berkeley, California 94710.

(c)      Paul Segall is currently the Chairman and Chief Executive Officer of 
         BioTime, Inc., 935 Pardee Street, Berkeley, California 94710.

         Judith Segall is currently the Vice President and Secretary of 
         BioTime, Inc.

(d)      Paul Segall and Judith Segall have not been  convicted  during the last
         five years in a criminal  proceeding,  excluding traffic  violations or
         similar misdemeanors.

(e)      Neither Paul Segall nor Judith  Segall has been a party during the last
         five years to any civil proceeding of a judicial or administrative body
         of competent jurisdiction, and neither of them has, as a result of such
         a  proceeding,  been  subject  to a  judgment,  decree  or final  order
         enjoining future violations of, or prohibiting or mandating  activities
         subject to, federal or state  securities  laws or finding any violation
         with respect to such laws.

(f)      Both Paul Segall and Judith Segall are citizens of the United States of
         America.

Item 3.  Source and Amount of Funds or Other Consideration

         The source of funds used by Paul  Segall and Judith  Segall to purchase
their Common Shares includes both personal funds and borrowed funds.

         Paul Segall and Judith Segall have each  executed a Customer  Agreement
with  NationsBanc  Montgomery  Securities  and a related  Representation  Letter
pursuant to which they may borrow  funds from time time.  On February  12, 1999,
the Company  distributed  subscription  rights pro rata to its shareholders (the
"Rights Offer").  During March 1999, Mr. and Mrs. Segall borrowed  approximately
$252,213 and $93,853,  respectively,  from NationsBanc Montgomery Securities for
the purpose of exercising the subscription  rights that were distributed to them
by the Company in the Rights Offer.

                               Page 4 of 7 Pages
<PAGE>



          Mr.  and Mrs.  Segall  have  pledged  all of their  Common  Shares  as
collateral  for such loans and have  agreed  not sell any  Common  Shares of the
Company while their margin loans are secured by their Common  Shares.  A copy of
each  of the  aforesaid  Customer  Agreements  and  Representation  Letters  has
previously  been  filed  as  an  Exhibit  to  this  Schedule  13D  and  each  is
incorporated herein by reference.

Item 4.  Purpose of Transaction

         These securities were purchased for investment.  Mr. and Ms. Segall may
acquire  additional  Common  Shares or sell all or some of their  Common  Shares
based upon market and economic circumstances.

         Mr. Segall is the Chairman and Chief Executive  Officer of the Company,
and Judith Segall is a Vice President and the Secretary of the Company. Both are
also directors of the Company. In their capacity as officers and directors, they
will participate in the management of the Company.

         Mr. and Ms.  Segall do not have any current  plans or  proposals  which
relate to or would result in (i) an extraordinary corporate transaction, such as
a merger,  reorganization or liquidation of the Company; (ii) a sale or transfer
of a material  amount of assets of the Company;  (iii) any change in the present
board  of  directors  or  management  of the  Company,  including  any  plans or
proposals  to change the  number or term of  directors  or to fill any  existing
vacancies on the board;  (iv) any material change in the present  capitalization
or  dividend  policy  of the  Company;  (v) any  other  material  change  in the
Company's  business or  corporate  structure;  (vi) any change in the  Company's
Articles  of  Incorporation  or Bylaws or other  action  which  may  impede  the
acquisition of control of the Company by any person;  (vii) causing any class of
the Company's  securities to be delisted from a national  securities exchange or
to cease to be authorized to be quoted in an inter-dealer  quotation system of a
registered national securities  association;  (viii) any of the Company's equity
securities becoming eligible for termination of registration pursuant to Section
12(g)(4)  of the  Exchange  Act;  or (ix)  any  action  similar  to any of those
enumerated above.

Item 5.  Interest in Securities of the Issuer

         (a) Paul Segall directly owns 543,245 Common Shares,  which  constitute
approximately  5.03% of the  10,804,733  Common Shares  outstanding on March 24,
1999.  Judith  Segall  directly owns 202,163  Common  Shares,  which  constitute
approximately  1.87% of the  10,804,733  Common Shares  outstanding on March 24,
1999. The forgoing number of outstanding Common Shares is based upon information
provided  by the  Company in its  Transition  Report on Form 10-K for the period
ending December 31, 1998, as filed with the Securities and Exchange Commission.

                               Page 5 of 7 Pages
<PAGE>


         (b) Mr. and Mrs.  Segall both have the sole power to vote and to direct
the vote,  and the sole power to dispose  and to direct  the  disposition,  with
respect to the shares held in their respective names.

         (c) On or about March 9, 1999,  Paul  Segall  purchased  25,868  Common
Shares,  and Judith Segall  purchased 9,626 Common Shares,  a price of $9.75 per
share,  through the exercise of subscription  rights  distributed to them by the
Company in the Rights Offer.  The total number of Common Shares  acquired by Mr.
and Mrs. Segall in the Rights Offer is less than 1% of the outstanding number of
Common Shares before the Rights Offer.

         (d) Mr. and Ms.  Segall  both have the sole power to vote and to direct
the vote,  and the sole power to dispose  and to direct  the  disposition,  with
respect to the shares held in their  respective  names. No other person is known
to have the right to  receive or the power to direct  the  receipt of  dividends
from, or the proceeds from the sale of, their Common Shares.

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect 
         to Securities of the Issuer

         Paul Segall and Judith Segall are husband and wife and may consult with
each other or act jointly with respect to (a) voting Common Shares held in their
respective names, (b) acquiring  additional Common Shares,  and (c) disposing of
Common  Shares  held in their  respective  names.  To the extent that the Common
Shares constitute  community property under California law, each spouse may have
the right to dispose of one-half of the shares  constituting  community property
held by the other spouse.

Item 7.  Material to Be Filed as Exhibits

None

                               Page 6 of 7 Pages
<PAGE>


Signature


         After  reasonable  inquiry and to the best of our  knowledge we certify
that the information set forth in the statement is true, complete and correct.

                                                /s/Paul Segall
Dated:  April 6, 1999                 ____________________________________
                                                Paul Segall

                                                /s/Judith Segall
Dated:  April 6, 1999                 ____________________________________
                                                Judith Segall


                               Page 7 of 7 Pages



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission